The New York Times recently published an article expressing grave concern about the use of puberty blockers to treat gender dysphoria in transgender adolescents. Unfortunately, the reporting ignored evidence and important context to weave a narrative portraying puberty blockers as far more risky than they actually are.
A lot of the "facts" about providing healthcare to transgender youth turn out to be not actually facts. We present here a summary of the evidence relating to transition-related health care for transgender adolescents.
Conclusions Not So NICE: A Critical Analysis of the NICE Evidence review of puberty blockers for children and adolescents with gender dysphoria
A critical look at the UK's National Health Service-commissioned review of transgender youth health services and the harm it has caused.
This article has been retracted. See editors' notice and link to a more detailed explanation. Comments have been closed. If you wish to continue to comment, go to the more recent article linked to at the beginning of this post.